These Alzheimer’s drugs were supposed to revolutionize the way we fight the disease. The reality is more complicated. Personal Finance April 20, 2026 A scientific report has raised questions about how much Leqimbi and Kisunla — the “breakthrough” Alzheimer’s drugs that have hit…
Neurocrine wants to develop new obesity drugs. It’s reportedly nearing an acquisition to accelerate that move. Personal Finance April 6, 2026 Soleno Therapeutics stock is soaring on Monday in premarket after a report that Neurocrine is nearing a deal to buy…
‘She spent over $1,000 a month on weight-loss drugs’: My son wrecked his finances after meeting his girlfriend. Who’s to blame? Personal Finance February 20, 2026 “My son is smart — he really is — but he was in love.”
Weight-loss drugs to compete on biggest stage with Super Bowl ads Personal Finance February 7, 2026 Weight-loss drugs to compete on biggest stage with Super Bowl ads
